Sarah Cannon Research Institute — Denver, Colorado

Sarah Cannon Research Institute is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute has participated in 41 clinical trials with 22 currently active.

Therapeutic areas: Non-Hodgkin Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC).

Sponsors: Novartis Pharmaceuticals, Regeneron Pharmaceuticals, IDEAYA Biosciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute?

Sarah Cannon Research Institute has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute conducted?

Sarah Cannon Research Institute has 41 clinical trials on record, with 22 currently active. Their work covers Non-Hodgkin Lymphoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC).

Is Sarah Cannon Research Institute accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.